ERWINAZE (asparaginase Erwinia chrysanthemi) for injection

Erwinaze (asparaginase Erwinia chrysanthemi) is used to treat acute lymphoblastic leukemia (ALL) in patients who have developed hypersensitivity to E. coli-derived asparaginase. Erwinaze is a cancer medication that interferes with the growth and spread of cancer cells. Brand Name: ERWINAZE (asparaginase Erwinia chrysanthemi) for injection, intramuscular (IM) or intravenous (IV) use Initial U.S. Approval: 2011

ERWINAZE (asparaginase Erwinia chrysanthemi) for injection Price In India
ERWINAZE (asparaginase Erwinia chrysanthemi) for injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ERWINAZE (asparaginase Erwinia chrysanthemi) for injection

asparaginase Erwinia chrysanthemi drug that is used to treat acute lymphoblastic leukemia (ALL) and is being studied in the treatment of some other types of cancer.

ERWINAZE (asparaginase Erwinia chrysanthemi) is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.

Asparaginase is an enzyme that is used as a medication and in food manufacturing. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. In food manufacturing it is used to decrease acrylamide.
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization’s List of Essential Medicines. It is often made from Escherichia coli (E. coli) or Erwinia chrysanthemi.

Drug (Brand / Generic): ERWINASE / Asparaginase Erwinia chrysanthemi
Current Indications: acute lymphoblastic leukemia (ALL)
Marketed by:: Jazz Pharmaceuticals, Inc.
Approval Date: 2011

10,000 International Units lyophilized powder per vial.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.